Switching to investigational once-weekly insulin icodec from other basal insulins demonstrated to be efficacious and well-tolerated for people with type 2 diabetes in phase 2 trial

    NEXT STORY
    CRISPR Therapeutics and Vertex Pharmaceuticals Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to CTX001™ for the Treatment of Sickle Cell Disease
    PREV STORY
    In vitro Diagnostics Market is Forecast to Rise at 4.5% CAGR and Reach USD 87.11 Billion by 2026; Launch of Altostar Molecular Diagnostics Workflow by Altona Diagnostics Gmbh Will Support Growth, says Fortune Business Insights
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Drug of Abuse Testing Market to Witness 9.6% CAGR till 2023: P&S Market Research

    NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- The drug of abuse testing market ...

    author_avatar
    NASDAQ Market News

    Equillium Expands Scientific and Clinical Advisory Team

    author_avatar
    NASDAQ Market News

    VitalFlow Reviews: Groundbreaking Report on VitalFlow for Prostate [Updated]

    author_avatar
    NASDAQ Market News